TRIM34 and Ferroptosis Sensitivity: The whole-genome CRISPR/Cas9 screen in the HCC cell line employing a subtoxic concentration of the ferroptosis inducer erastin revealed that TRIM34 increases ferroptosis sensitivity and increases immunotherapy efficacy in HCC. Here, TRIM34 is linked to hepatocellular carcinoma.